company background image
CMP

Compumedics ASX:CMP Stock Report

Last Price

AU$0.23

Market Cap

AU$38.1m

7D

-2.1%

1Y

-31.3%

Updated

02 Dec, 2022

Data

Company Financials
CMP fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance3/6
Financial Health4/6
Dividends0/6

CMP Stock Overview

Compumedics Limited researches, develops, manufactures, sells, and distributes medical devices in Australia, the Asia Pacific, the Americas, Europe, and the Middle East.

Compumedics Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Compumedics
Historical stock prices
Current Share PriceAU$0.23
52 Week HighAU$0.45
52 Week LowAU$0.15
Beta1.12
1 Month Change0%
3 Month Change-14.82%
1 Year Change-31.34%
3 Year Change-72.94%
5 Year Change-37.84%
Change since IPO-74.16%

Recent News & Updates

Some Shareholders May Object To A Pay Rise For Compumedics Limited's (ASX:CMP) CEO This Year

Oct 19
Some Shareholders May Object To A Pay Rise For Compumedics Limited's (ASX:CMP) CEO This Year

Compumedics (ASX:CMP) Seems To Use Debt Quite Sensibly

Oct 14
Compumedics (ASX:CMP) Seems To Use Debt Quite Sensibly

Recent updates

Some Shareholders May Object To A Pay Rise For Compumedics Limited's (ASX:CMP) CEO This Year

Oct 19
Some Shareholders May Object To A Pay Rise For Compumedics Limited's (ASX:CMP) CEO This Year

Compumedics (ASX:CMP) Seems To Use Debt Quite Sensibly

Oct 14
Compumedics (ASX:CMP) Seems To Use Debt Quite Sensibly

Is Compumedics (ASX:CMP) Using Debt Sensibly?

May 02
Is Compumedics (ASX:CMP) Using Debt Sensibly?

Compumedics (ASX:CMP) May Have Issues Allocating Its Capital

Dec 08
Compumedics (ASX:CMP) May Have Issues Allocating Its Capital

Compumedics (ASX:CMP) Will Want To Turn Around Its Return Trends

Aug 09
Compumedics (ASX:CMP) Will Want To Turn Around Its Return Trends

Here's Why Compumedics (ASX:CMP) Has A Meaningful Debt Burden

Jun 10
Here's Why Compumedics (ASX:CMP) Has A Meaningful Debt Burden

Returns On Capital Signal Tricky Times Ahead For Compumedics (ASX:CMP)

May 06
Returns On Capital Signal Tricky Times Ahead For Compumedics (ASX:CMP)

These 4 Measures Indicate That Compumedics (ASX:CMP) Is Using Debt Extensively

Feb 25
These 4 Measures Indicate That Compumedics (ASX:CMP) Is Using Debt Extensively

How Much Did Compumedics'(ASX:CMP) Shareholders Earn From Share Price Movements Over The Last Year?

Dec 01
How Much Did Compumedics'(ASX:CMP) Shareholders Earn From Share Price Movements Over The Last Year?

Shareholder Returns

CMPAU Medical EquipmentAU Market
7D-2.1%1.7%1.3%
1Y-31.3%-5.8%-1.1%

Return vs Industry: CMP underperformed the Australian Medical Equipment industry which returned -5.8% over the past year.

Return vs Market: CMP underperformed the Australian Market which returned -1.1% over the past year.

Price Volatility

Is CMP's price volatile compared to industry and market?
CMP volatility
CMP Average Weekly Movement8.1%
Medical Equipment Industry Average Movement10.0%
Market Average Movement9.0%
10% most volatile stocks in AU Market16.0%
10% least volatile stocks in AU Market4.1%

Stable Share Price: CMP is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: CMP's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1987135David Burtonhttps://www.compumedics.com.au

Compumedics Limited researches, develops, manufactures, sells, and distributes medical devices in Australia, the Asia Pacific, the Americas, Europe, and the Middle East. It provides sleep diagnostics products, including Grael 4K PSG:EEG amplifiers; Somté PSG; Siesta 802, an ambulatory recording device; Okti; Grael PSG; Grael DC; Somfit/Somfit Pro, a wearable device; TCM5 FLEX Transcutaneous monitor; and Somté, an investigative tool. The company also provides neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory studies; Grael 4K PSG:EEG amplifiers; Grael 4K-EEG amplifiers; Grael LT EEG System amplifiers; Neuvo 64-512 Channel LTM EEG monitoring systems; Xegis Forte EMG/EP; and Xegis G:NEO 2 Channel EMG/EP systems.

Compumedics Limited Fundamentals Summary

How do Compumedics's earnings and revenue compare to its market cap?
CMP fundamental statistics
Market CapAU$38.09m
Earnings (TTM)AU$1.36m
Revenue (TTM)AU$37.76m

30.1x

P/E Ratio

1.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CMP income statement (TTM)
RevenueAU$37.76m
Cost of RevenueAU$18.44m
Gross ProfitAU$19.32m
Other ExpensesAU$17.96m
EarningsAU$1.36m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.0076
Gross Margin51.17%
Net Profit Margin3.59%
Debt/Equity Ratio27.1%

How did CMP perform over the long term?

See historical performance and comparison